Your browser doesn't support javascript.
loading
Fertility preservation practices in pediatric and adolescent cancer patients undergoing HSCT in Europe: a population-based survey.
Diesch, T; Rovo, A; von der Weid, N; Faraci, M; Pillon, M; Dalissier, A; Dalle, J-H; Bader, P.
Afiliação
  • Diesch T; Division of Oncology/Hematology, University Children's Hospital Basel UKBB, Basel, Switzerland.
  • Rovo A; Department of Hematology, University of Bern, Bern, Switzerland.
  • von der Weid N; Division of Oncology/Hematology, University Children's Hospital Basel UKBB, Basel, Switzerland.
  • Faraci M; Division of Oncology/Hematology, HSCT Unit, Gaslini Research Institute G. Gaslini, Genova, Italy.
  • Pillon M; Division of Pediatric Oncology/Hematology, Hospital of Padua, Padua, Italy.
  • Dalissier A; EBMT Pediatric Disease Working Party, Paris, France.
  • Dalle JH; Pediatric Hematology Immunology, Robert Debre Hospital, Paris, France.
  • Bader P; Division of Stem Cell Transplantation and Immunology, Hospital for Children and Adolescents of Frankfurt, Frankfurt, Germany.
Bone Marrow Transplant ; 52(7): 1022-1028, 2017 Jul.
Article em En | MEDLINE | ID: mdl-28112743
ABSTRACT
Chemotherapy and irradiation can affect the gonads, leading to impairment of pubertal development and/or infertility. Fertility preservation (FP) is therefore a crucial endeavor in hematopoietic stem cell transplantation (HSCT) because of the severe impact of infertility on the quality of life of long-term survivors. Despite the existence of different international guidelines, FP counseling and procedures are not routinely implemented as part of patient care. We present herein a survey conducted by the Pediatric Working Party of the European Society for Blood and Marrow Transplantation (EBMT), which aims to analyze and compare different FP practices for children and adolescents across EBMT centers in 2013. A total of 177 pediatric centers reporting to the EBMT were contacted; of this number, 38 centers (21%) located in 16 different countries responded. These centers reported 834 patients receiving HSCT in 2013 (73% prepubertal), corresponding to 22% of all children (n=3789) undergoing HSCT in EBMT reporting centers. Overall, 39% of the reported patients received counseling and 29% received an FP procedure. The increased need for FP programs, extended education for patient-care teams, and more personal resources and funding emerged from this survey as pivotal factors necessary to support and implement such programs.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Fertilidade / Infertilidade Feminina / Infertilidade Masculina Tipo de estudo: Clinical_trials / Guideline / Qualitative_research Limite: Adolescent / Child / Female / Humans / Male País/Região como assunto: Europa Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Fertilidade / Infertilidade Feminina / Infertilidade Masculina Tipo de estudo: Clinical_trials / Guideline / Qualitative_research Limite: Adolescent / Child / Female / Humans / Male País/Região como assunto: Europa Idioma: En Ano de publicação: 2017 Tipo de documento: Article